EORTC Endocrine Tumours Group Autumn Meeting
October 21, 2022
Florence, IT
The EORTC Endocrine Tumours Autumn meeting will be held in Florence, Italy on 21 October from 09:30-18:30 CEST. It is only open to individual or site staff members of the group.
Registrations for the meeting are now closed. Please send an email to events@eortc.org if you would still like to attend.
Agenda
Friday 21 October
The meeting will have a joined session with the EORTC Head and Neck Cancer Group (HNCG). On Friday morning (9h30), parallel sessions will take place, and you are welcome to join either the EnTG or the HNCG session, depending on your interest.
| 09:30-10:00 | Keynote lecture: Update on WHO classification of thyroid cancer. (Prof. G. Tallini) * |
| 10.00-10.15 | Discussion |
| 10.15-10.45 | Molecular markers for aggressive behaviour in intermediate risk. (Dr. M. Melo.) * |
| 10.45-11.00 | Discussion |
| 11:00-11:30 | Coffee and welcome |
| 11.30-12.00 | ITCO network as a model for networking for thyroid cancer research (Prof Cosimo Durante) * |
| 12.00-12.15 | Discussion |
| 12.15-13.00 | Update on clinical trials in development (Prof Romana Netea-Maier)* |
| 13:00-14:00 | Lunch |
| 14:00-15:30 | New proposals * |
| 15:30-16:00 | Coffee break |
| 16:00-17:30 | Parallel brainstorm sessions |
| 17.30-18.30 | Presentation of brainstorm results |
| 20:00 | Dinner |
* These sessions could also be followed remotely. Face-to-face attendance is required for the other sessions.
The aim of the brainstorming sessions is to discuss the state of the art in the various domains, what EORTC can do to improve this, with as purpose to generate ideas for new trial proposals.
The selected topics are:
- Application to HORIZON-MISS-2023-CANCER-01-03 call: Pragmatic clinical trials on minimally invasive diagnostics (submission deadline April 2023)
- Developing studies in the Post-operative setting of HNSCC
- Developing studies for microcarcinoma
- What is next in LA-HNSCC setting following the results from Keynote 412 – CRT +/- pembro ?
- What is after UPSTREAM “A pilot study of personalized biomarker-based treatment strategy or immunotherapy in patients with recurrent/metastatic squamous cell carcinoma of the head and neck”: i.e., UPSTREAM2 in first line recurrent/metastatic HNSCC setting?
- Developing studies for Salivary gland cancer
Venue
NH Collection Firenze Palazzo Gaddi
Meeting room Sala Gaddi
Via del Giglio 9, 50123 Firenze, Italy
Click here for directions. The meeting venue is at walking distance from the main railway station (Santa Maria Novella), located in downtown Florence.
Hotel
A room in the venue can be reserved via this link: www.nh-hotels.com/event/eortc. Note that the discount will expire on 19 September and only a limited number of rooms are available. Many other hotel options are available near the venue in downtown Florence.
Dinner
The dinner on Friday evening (20:00) will take place at the meeting venue (NH Collection Firenze Palazzo Gaddi).
Next events
ESTRO 2024
May 3 - May 7
Glasgow
EORTC Lung Cancer Group Spring Meeting
May 16 - May 18
Malaga, Spain
EORTC Gynecological Cancer Group Spring Meeting
May 16 - May 17
Barcelona, Spain
EORTC Genito-Urinary Cancer Group Spring Meeting
May 17
Barcelona, Spain
The 10+1 Santorini Conference
May 21 - May 24
Santorini
